Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 216 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
14 Sep 2026
Director indirect
Sold at will
58,000
$5.69M
12.2%
11 Sep 2026
Director indirect
Sold at will
45,000
$4.36M
8.6%
26 Nov 2025
Director
Sold at will
17,840
$1.68M
23.3%
6 Nov 2025
10% owner
Sold at will
5,670,000
$508.60M
100%
6 Nov 2025
10% owner
Sold at will
2,845,283
$255.22M
100%
6 Nov 2025
10% owner
Sold at will
2,786,040
$249.91M
100%
21 Aug 2025
Director
Sold at will
15,699
$1.39M
21.1%
7 Feb 2025
Director indirect
Bought
45,500
$2.96M
9.6%
6 Feb 2025
Director indirect
Bought
44,000
$2.87M
10.2%
5 Feb 2025
Director indirect
Bought
43,000
$2.85M
11.1%
19 Nov 2024
Director indirect
Bought
77,800
$5.02M
25.1%
18 Nov 2024
Director indirect
Bought
75,500
$4.90M
32.2%
15 Nov 2024
Director indirect
Bought
77,500
$4.96M
49.4%
14 Nov 2024
Director indirect
Bought
78,000
$5.04M
98.7%
13 Nov 2024
Director indirect
Bought
79,000
$5.01M
opened
30 May 2024
Executive Vice President & CDO
Sold at will
14,976
$1.82M
20.7%
22 May 2024
Group President
Sold at will
12,786
$1.67M
69.6%
15 May 2024
EVP & CFO
Sold at will
14,493
$1.97M
23.5%
23 Aug 2023
Executive Vice President & CDO
Sold at will
12,661
$1.93M
18.5%
16 May 2023
Executive Group President
Sold at will
9,869
$1.97M
46.4%
11 May 2023
Executive Group President
Sold at will
43,311
$8.75M
67.1%
13 Feb 2023
EVP Research Prod & Innovation
Sold, plan not stated
9,741
$2.47M
67.1%
3 Feb 2023
Director
Sold, plan not stated
5,234
$1.40M
84.0%
1 Feb 2023
President and CEO
Sold, plan not stated
6,831
$1.91M
5.4%
23 Jan 2023
President and CEO
Sold, plan not stated
11,705
$3.16M
8.5%
9 Sep 2022
EVP Research Prod & Innovation
Sold, plan not stated
7,559
$1.91M
69.6%
25 Aug 2022
President and CEO
Sold, plan not stated
19,709
$5.28M
14.4%
25 Aug 2022
Executive Group President
Sold, plan not stated
6,667
$1.83M
21.4%
25 Aug 2022
Director
Sold, plan not stated
4,736
$1.30M
13.3%
11 May 2022
Executive Group President
Sold, plan not stated
8,256
$1.90M
21.0%
4 May 2022
EVP, Enterprise Mkg & CDataO
Sold, plan not stated
20,032
$4.91M
27.2%
11 Mar 2022
President and CEO
Sold, plan not stated
127,919
$34.13M
62.8%
10 Feb 2022
Chairman, Clinique Labs, LLC
Sold, plan not stated
700,000
$214.96M
100%
9 Feb 2022
Group President
Sold, plan not stated
10,027
$3.21M
60.3%
4 Feb 2022
Group President
Sold, plan not stated
23,248
$7.30M
77.9%
4 Feb 2022
EVP-Global Human Resources
Sold, plan not stated
16,389
$5.08M
100%
2 Dec 2021
Executive Chairman
Sold, plan not stated
40,141
$13.20M
100%
1 Dec 2021
Executive Chairman
Sold, plan not stated
18,579
$6.13M
82.3%
17 Nov 2021
10% owner
Sold, plan not stated
2,000,000
$684.46M
100%
10 Nov 2021
EVP & CFO
Sold, plan not stated
47,638
$16.43M
53.1%
4 Nov 2021
Executive Group President
Sold, plan not stated
9,043
$3.08M
18.7%
3 Nov 2021
Group President
Sold, plan not stated
6,000
$2.01M
47.6%
2 Nov 2021
President and CEO
Sold, plan not stated
10,432
$3.31M
12.1%
3 Sep 2021
President and CEO
Sold, plan not stated
14,961
$5.13M
16.5%
3 Sep 2021
EVP-Global Human Resources
Sold, plan not stated
2,947
$1.01M
100%
2 Sep 2021
Vice Chairman
Sold, plan not stated
3,451
$1.18M
100%
25 Aug 2021
10% owner
Sold, plan not stated
184,293
$61.91M
100%
20 Aug 2021
Group President
Sold, plan not stated
6,500
$2.13M
76.3%
20 Aug 2021
Director
Sold, plan not stated
4,576
$1.51M
12.9%
14 Jul 2021
EVP & CFO
Sold, plan not stated
53,531
$17.40M
63.1%
Showing 1–50 of 216. Page 1 of 5 Older →